Otofarma SpA (MIL:OTO) Loans Receivable: €0.00 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.70
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Loans Receivable?

Otofarma SpA MIL:OTO 16 Loans Receivable is €0.00 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Loans Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.

Otofarma SpA Loans Receivable Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Loans Receivable Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Loans Receivable
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Loans Receivable 0.00 0.00
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.00 Mil mean?
Otofarma SpA (MIL:OTO) has a Loans Receivable of €0.00 Mil as of Dec. 2024. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Loans Receivable too high?
Otofarma SpA's current Loans Receivable is €0.00 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Loans Receivable compare to ABT and SYK?
Otofarma SpA's Loans Receivable of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Loans Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Loans Receivable of €0.00 Mil. The current Loans Receivable is €0.00 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Loans Receivable is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.70
Price